|
Pharmacy Clinical Policy Bulletins
Subject: Antidepressants
Class Edit Summary*
 |
 |
Status |
 |
Drug |
 |
PR |
 |
PR-QL |
 |
PR-AL |
 |
ST |
 |
M EX‡ |
 |
 |
 |
Selective Serotonin Reuptake Inhibitors (SSRIs) |
 |
 |
 |
P |
 |
citalopram |
 |
|
 |
X |
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
fluoxetine |
 |
|
 |
X |
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
fluvoxamine |
 |
|
 |
X |
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
paroxetine |
 |
|
 |
X |
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
sertraline |
 |
|
 |
X |
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
Paxil CR® (paroxetine SR) |
 |
|
 |
|
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Celexa® (citalopram) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Lexapro® (escitalopram) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Paxil® (paroxetine) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Pexeva® (paroxetine) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Prozac® (fluoxetine) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Prozac® Weekly (fluoxetine) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Rapiflux® (fluoxetine) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Zoloft® (sertraline) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
Selective Norepinephrine Reuptake Inhibitors (SNRIs) |
 |
 |
 |
P |
 |
Effexor XR® (venlafaxine SR) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Cymbalta® (duloxetine) |
 |
X |
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Effexor® (venlafaxine) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
Tricyclic Antidepressants |
 |
 |
 |
P |
 |
amitriptyline |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
amoxapine |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
clomipramine |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
desipramine |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
doxepin |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
imipramine |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
nortriptyline |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
protriptyline |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Anafranil® (clomipramaine) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Asendin® (amoxapine) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Aventil® (nortriptyline) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Elavil® (amitriptyline) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Norpramine® (desipramine) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Pamelor® (nortriptyline) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Sinequan® (doxepin) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Surmontil® (trimipramine) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Tofranil® (imipramine) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Vivactil® (protriptyline) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
Tretracyclic Antidepressants |
 |
 |
 |
P |
 |
maprotiline |
 |
|
 |
X |
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
mirtazapine |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Ludiomil® (maprotiline) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Remeron® /Solutab (mirtazapine) |
 |
|
 |
|
 |
|
 |
X |
 |
X |
 |
 |
 |
Miscellaneous Antidepressants |
 |
 |
 |
P |
 |
budeprion |
 |
|
 |
X |
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
bupropion, bupropion SR |
 |
|
 |
X |
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
trazodone |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
P |
 |
Wellbutrin XL® (bupropion SR) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
NP |
 |
Desyrel® (trazodone) |
 |
|
 |
|
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
nefazodone |
 |
|
 |
|
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Emsam® (selegiline td patch 24-Hr) |
 |
|
 |
|
 |
|
 |
|
 |
X |
 |
 |
 |
FE |
 |
Serzone® (nefazodone) |
 |
|
 |
|
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Trazamine Pak® (trazodone tab/nutritional supp cap pack) |
 |
|
 |
|
 |
|
 |
|
 |
X |
 |
 |
 |
FE |
 |
Wellbutrin® (bupropion) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
FE |
 |
Wellbutrin SR® (bupropion SR) |
 |
|
 |
X |
 |
|
 |
X |
 |
X |
 |
 |
 |
Monoamine Oxidase Inhibitors |
 |
 |
 |
NP |
 |
Marplan®(isocarboxazid) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Nardil®(phenelzine) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
 |
NP |
 |
Parnate®(tranylcypromine) |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
*P = Preferred; FE = Formulary Excluded; NP = Nonpreferred
PR = Precertification; QL = Quantity Limits; AL = Age Limits; ST = Step-Therapy
‡M EX = Medical Exception - This means the physician or health care professional must obtain a medical exception from Aetna, in order for the medication to be eligible for coverage. Medical Exception criteria apply to Formulary Excluded drugs for members enrolled in or covered by closed benefits plans, and also apply to Step-Therapy drugs in cases where a member's physician believes it is medically necessary for the member to use a step-therapy drug in the first instance without a trial of the prerequisite alternative drug(s).
Important Note
This Pharmacy Clinical Policy Bulletin expresses Aetna's determination of whether certain services or supplies are medically necessary. Aetna has reached these conclusions based upon a review of currently available clinical information (including clinical outcome studies in the peer-reviewed published medical literature, regulatory status of the technology, evidence-based guidelines of public health and health research agencies, evidence-based guidelines and positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas, and other relevant factors). Aetna expressly reserves the right to revise these conclusions as clinical information changes, and welcomes further relevant information. Each benefits plan defines which services are covered, which are excluded, and which are subject to dollar caps or other limits. Members and their health care providers will need to consult the member's benefits plan to determine if there are any exclusions or other benefit limitations applicable to this service or supply. The conclusion that a particular service or supply is medically necessary does not constitute a representation or warranty that this service or supply is covered (that is, will be paid for by Aetna) for a particular member. The member's benefits plan determines coverage. Some plans exclude coverage for services or supplies that Aetna considers medically necessary. If there is a discrepancy between this policy and a member's plan of benefits, the benefits plan will govern. In addition, coverage may be mandated by applicable legal requirements of a state, the federal government or CMS for Medicare and Medicaid members. CMS's Coverage Database can be found on the following website: http://www.cms.hhs.gov/center/coverage.asp.
Policy
- Precertification Criteria
Under some plans, including plans that use an open or closed formulary, certain antidepressants are subject to precertification as specifically described below.
- Cymbalta is subject to precertification. If precertification requirements apply, Aetna considers Cymbalta to be medically necessary for those members who meet the following precertification criteria:
A documented diagnosis of one of the following:
Cymbalta: major depressive disorder OR diabetic peripheral neuropathic pain
- Bupropion, bupropion SR, citalopram, fluoxetine, fluvoxamine, maprotiline, paroxetine, sertraline, Celexa, Cymbalta, Effexor, Effexor XR, Lexapro, Paxil, Pexeva, Prozac, Prozac Weekly, Rapiflux, Wellbutrin, Wellbutrin SR, Wellbutrin XL and Zoloft may be subject to quantity limits.
According to the manufacturers, these antidepressants can be dosed up to a maximum daily dose at the interval(s) as indicated in the table below. A quantity of each drug will be considered medically necessary as indicated in the table below; for Cymbalta, the member must also fulfill criteria A above.
 |
 |
Drug |
 |
Maximum DAILY Dose per Package Insert |
 |
Doses per day |
 |
Dosage Strengths |
 |
Quantity Limits |
 |
 |
 |
bupropion
Wellbutrin |
 |
450 mg |
 |
Three |
 |
75 mg, 100 mg |
 |
Up to 180 tablets in 30 days |
 |
 |
 |
bupropion SR
Wellbutrin SR
budeprion
|
 |
400 mg |
 |
One or two |
 |
100, 150, 200 mg |
 |
Up to 60 tablets in 30 days |
 |
 |
 |
Wellbutrin XL
|
 |
450 mg |
 |
One |
 |
150 mg |
 |
Up to 30 tablets in 30 days |
 |
 |
 |
Wellbutrin XL
|
 |
450 mg |
 |
One |
 |
300 mg |
 |
Up to 30 tablets in 30 days |
 |
 |
 |
citalopram
Celexa
|
 |
40 mg |
 |
One |
 |
10, 20, 40 mg |
 |
Up to 30 tablets in 30 days |
 |
 |
 |
Cymbalta |
 |
60 mg |
 |
One or two |
 |
20 mg, 30 mg |
 |
Up to 60 capsules in 30 days |
 |
 |
 |
Cymbalta |
 |
60 mg |
 |
One or two |
 |
60 mg |
 |
Up to 30 capsules in 30 days |
 |
 |
 |
Effexor |
 |
375 mg |
 |
Two or three |
 |
25mg, 100 mg |
 |
Up to 90 tablets in 30 days |
 |
 |
 |
Effexor |
 |
375 mg |
 |
Two or three |
 |
37.5 mg |
 |
Up to 120 tablets in 30 days |
 |
 |
 |
Effexor |
 |
375 mg |
 |
Two or three |
 |
50 mg |
 |
Up to 180 tablets in 30 days |
 |
 |
 |
Effexor |
 |
375 mg |
 |
Two or three |
 |
75 mg |
 |
Up to 150 tablets in 30 days |
 |
 |
 |
Effexor XR |
 |
375 mg |
 |
One |
 |
37.5 , 75 mg |
 |
Up to 30 capsules in 30 days |
 |
 |
 |
Effexor XR |
 |
375 mg |
 |
Two |
 |
150 mg |
 |
Up to 60 capsules in 30 days |
 |
 |
 |
fluoxetine
Prozac |
 |
80 mg |
 |
One or two |
 |
10 mg |
 |
Up to 30 tablets or capsules in 30 days |
 |
 |
 |
fluoxetine
Prozac |
 |
80 mg |
 |
One or two |
 |
40 mg |
 |
Up to 60 capsules in 30 days |
 |
 |
 |
fluoxetine
Prozac |
 |
80 mg |
 |
One or two |
 |
20 mg capsules |
 |
Up to 120 capsules in 30 days |
 |
 |
 |
fluoxetine
Rapiflux
|
 |
80 mg |
 |
One or two |
 |
20 mg tablets |
 |
Up to 30 tablets in 30 days |
 |
 |
 |
fluoxetine
Prozac |
 |
80 mg |
 |
One or two |
 |
Liquid 20 mg/5ml |
 |
Up to 300 ml in 30 days (10ml/day) |
 |
 |
 |
Prozac Weekly |
 |
90 mg |
 |
One weekly |
 |
90 mg |
 |
Up to 4 capsules in 28 days |
 |
 |
 |
fluvoxamine |
 |
300 mg |
 |
One or two |
 |
25 mg, 50 mg |
 |
Up to 30 tablets in 30 days |
 |
 |
 |
fluvoxamine |
 |
300 mg |
|
|